• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $ADOC

    Edoc Acquisition Corp.

    Subscribe to $ADOC
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Edoc Acquisition Corp. is a blank check company. The company intends to focus on businesses primarily operating in the health care and health care provider space in North America and the Asia-Pacific. Edoc Acquisition Corp. was incorporated in 2020 and is based in Victor, New York.

    IPO Year: 2020

    Exchange: NASDAQ

    Website: edocmed.net

    Recent Analyst Ratings for Edoc Acquisition Corp.

    DatePrice TargetRatingAnalyst
    See more ratings

    Edoc Acquisition Corp. SEC Filings

    View All

    SEC Form 15-12G filed by Edoc Acquisition Corp.

    15-12G - Edoc Acquisition Corp. (0001824884) (Filer)

    4/1/24 6:02:12 AM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Edoc Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

    8-K - Edoc Acquisition Corp. (0001824884) (Filer)

    3/28/24 5:16:10 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 25-NSE filed by Edoc Acquisition Corp.

    25-NSE - Edoc Acquisition Corp. (0001824884) (Subject)

    3/22/24 8:52:21 AM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Edoc Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Edoc Acquisition Corp. (0001824884) (Filer)

    3/11/24 5:00:47 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 425 filed by Edoc Acquisition Corp.

    425 - Edoc Acquisition Corp. (0001824884) (Subject)

    3/7/24 3:59:07 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 425 filed by Edoc Acquisition Corp.

    425 - Edoc Acquisition Corp. (0001824884) (Subject)

    3/1/24 5:24:48 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Edoc Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8-K - Edoc Acquisition Corp. (0001824884) (Filer)

    3/1/24 5:22:54 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Edoc Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits

    8-K - Edoc Acquisition Corp. (0001824884) (Filer)

    2/27/24 5:28:08 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 425 filed by Edoc Acquisition Corp.

    425 - Edoc Acquisition Corp. (0001824884) (Subject)

    2/27/24 5:29:49 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 425 filed by Edoc Acquisition Corp.

    425 - Edoc Acquisition Corp. (0001824884) (Subject)

    2/13/24 5:02:51 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Edoc Acquisition Corp. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Yakira Capital Management, Inc. disposed of $2,662,742 worth of Class A Ordinary Shares (248,622 units at $10.71)

    4 - Edoc Acquisition Corp. (0001824884) (Issuer)

    2/23/23 5:01:04 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 3: New insider Yakira Capital Management, Inc. claimed ownership of 275,000 units of Class A Ordinary Shares

    3 - Edoc Acquisition Corp. (0001824884) (Issuer)

    1/26/23 2:36:23 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 3 filed by new insider Li Yan Michael

    3 - Edoc Acquisition Corp. (0001824884) (Issuer)

    11/7/22 5:20:00 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 3 filed by new insider Zheng Jintao

    3 - Edoc Acquisition Corp. (0001824884) (Issuer)

    11/7/22 5:18:07 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Edoc Acquisition Corp. Press Releases

    Fastest customizable press release news feed in the world

    View All

    Edoc Acquisition Corp. Announces Postponement of Special Meeting of Shareholders on Proposed Business Combination

    Victor, NY, Feb. 27, 2024 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (NASDAQ:ADOC) ("EDOC") announced today that it has postponed its extraordinary general meeting of its shareholders (the "Meeting") to approve its proposed initial business combination, which was re-scheduled from February 26, 2024 to February 28, 2024, has been further postponed to 4:30p.m. Eastern Time, on Tuesday, March 5, 2024. At the Meeting, shareholders of EDOC will be asked to vote on proposals to approve, among other things, its proposed initial business combination with Australian Oilseeds Holdings Limited, a Cayman Islands exempted company ("Pubco"), pursuant to a Business Combination Agreement by and among EDOC

    2/27/24 5:32:10 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Edoc Acquisition Corp. Announces Postponement of Special Meeting of Stockholders on Proposed Business Combination

    Victor, NY, Feb. 23, 2024 (GLOBE NEWSWIRE) --  EDOC Acquisition Corp. (NASDAQ:ADOC) ("EDOC") announced today that it has postponed its extraordinary general meeting of its shareholders (the "Meeting") to approve its proposed initial business combination, which was scheduled for February 26, 2024, has been postponed to 10:00 a.m. Eastern Time, on Wednesday, February 28, 2024. At the Meeting, shareholders of EDOC will be asked to vote on proposals to approve, among other things, its proposed initial business combination with Australian Oilseeds Holdings Limited, a Cayman Islands exempted company ("Pubco"), pursuant to a Business Combination Agreement by and among EDOC, American Physicians LL

    2/23/24 5:45:00 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Australian Oilseeds and EDOC Acquisition Corp. Announce Effectiveness of Registration Statement and Date of Shareholder Meeting to Approve Proposed Business Combination

    ~ Shareholder Meeting of EDOC Acquisition Corp. to Approve Business CombinationScheduled for February 26, 2024 ~ ~ EDOC Shareholders of Record as of February 2, 2024, are Eligible to Vote at Meeting ~ ~ Upon Closing, Australian Oilseeds Investments Pty Ltd. is Expected to Trade on Nasdaq Under the Ticker "COOT" ~ Victor, NY and Cootamundra New South Wales, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Australian Oilseeds Holdings Limited, a Cayman Islands exempted company ("Australian Oilseeds" or "Pubco") and EDOC Acquisition Corp., a publicly-traded special purpose acquisition company ("EDOC") (NASDAQ:ADOC, ADOCW, ADOCR))), today announced that the Securities and Exchange Commission ("SEC")

    2/7/24 3:00:00 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Edoc Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

    Victor, NY, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Edoc Acquisition Corp. (NASDAQ: ADOC) (the "Company") announced that it received a letter from The Nasdaq Capital Market ("Nasdaq") on November 30, 2023 indicating that (i) the Company's failure to file its Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the "Form 10-Q"), in violation of the Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the "Rule"), serves as an additional basis for delisting the Company's securities from Nasdaq based on Listing Rule 5810(b) and (ii) the Nasdaq Hearings Panel (the "Panel") will consider this additional deficiency in its decision regarding the Company's cont

    12/6/23 5:26:57 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Arena Investors, Australian Oilseeds Holdings Limited and EDOC Acquisition Corp. Announce an Investment of up to $7 Million and Plans for a $50 Million ELOC

    NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Arena Investors, LP ("Arena"), a $3.5 billion institutional asset manager, has entered into an agreement with Australian Oilseeds Holdings Limited ("Australian Oilseeds" or "Pubco"), which is a holding company whose subsidiaries following the Business Combination have engaged for more than 20 years in the business of processing, manufacturing and selling of non-GMO oilseeds and organic and non-organic food-grade oils, for the rapidly growing oilseeds market, and EDOC Acquisition Corp. (NASDAQ:ADOC), a special purpose company ("EDOC"), to make a convertible debenture and warrant PIPE investment (the "PIPE") of up to $7 million in connection with t

    8/24/23 8:49:35 AM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    EDOC Acquisition Corp. Announces Business Combination Agreement with Australian Oilseeds Investments Pty Ltd.,

    ~ Over the past 20 years, the Company has grown the business to be the largest cold pressing oil plant in Australia, pressing strictly GMO free conventional and organic oilseeds ~ ~ Combined company expected to have a post-transaction enterprise value of approximately $190 million ~ ~ The global oilseeds market is estimated at $264.87 billion in 2022 ~ ~ The oilseeds market is expected to grow to $340.44 billion in 2026 at a compound annual growth rate (CAGR) of 5.7% ~ Victor, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (NASDAQ:ADOC, ADOCR, ADOCW, "EDOC"))), a special purpose acquisition company, and Australian Oilseeds Investments Pty Ltd., an Australian prop

    12/7/22 9:33:03 AM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    EDOC Acquisition Corp. Announces Voting Results of Extraordinary General Meeting to Approve the Extension Amendment

    New York, NY, Aug. 15, 2022 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (NASDAQ:ADOC, ADOCR, ADOCW, "EDOC" or the "Company"))), a special purpose acquisition company, announced today that the Company's shareholders voted in favor of the proposal to amend its charter (the "Extension Amendment") to extend the date by which the Company has to complete a business combination from August 12, 2022 to February 12, 2023 (the "Extension"), at the extraordinary general meeting of EDOC shareholders that took place August 12, 2022 at 8:00 pm ET. The Extension Amendment was approved by a vote of approximately 99% of the ordinary shares voted, which represented approximately 68.1% of the outstanding ordi

    8/15/22 9:16:24 AM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Edoc Acquisition Corp. Announces Termination of Merger Agreement with Calidi Biotherapeutics, Inc.

    New York, NY, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Edoc Acquisition Corp. (NASDAQ:ADOC, ADOCR, ADOCW, "EDOC" or the "Company"))), a special purpose acquisition company, announced today the termination of its previously announced agreement and plan of merger (the "Merger Agreement") with Calidi Biotherapeutics, Inc. ("Calidi"). Although Edoc and Calidi may continue to discuss the possibility of engaging in a business combination, there can be no assurance that those discussions will result in a transaction between Edoc and Calidi proceeding on the current terms of the Business Combination, if at all. As a result of the termination of the Merger Agreement, Edoc intends to promptly begin simulta

    8/12/22 5:56:22 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Edoc Acquisition Corp. Announce Postponement of Special Meeting of Shareholders to Extend the Deadline to Consummate an Initial Business Combination

      ● Extraordinary General Meeting of Edoc's shareholders postponed until August 12, 2022, at 8:00 p.m., Eastern Time NEW YORK, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Edoc Acquisition Corp. (Nasdaq: ADOC, ADOCR, ADOCW, "EDOC" or the "Company"), today announced the postponement of Edoc's extraordinary general meeting of shareholders (the "Special Meeting") originally scheduled to be held on August 12, 2022 at 10:00 am Eastern Time. The Special Meeting has been postponed until August 12, 2022 at 8:00 p.m. Eastern Time. As previously announced, the Special Meeting will occur at the offices of Ellenoff Grossman and Schole LLP located at 1345 Avenue of the Americas, 11th Floor, New York, New Y

    8/12/22 10:02:34 AM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Edoc Acquisition Corp. Reminds Shareholders to Vote and Announces Additional Contribution for Extension Amendment

    NEW YORK, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Edoc Acquisition Corp. (Nasdaq: ADOC, ADOCR, ADOCW, "EDOC" or the "Company") encourages its shareholders to vote in favor of the proposal to amend its charter (the "Extension Amendment") to extend the date by which the Company has to complete a business combination from August 12, 2022 to February 12, 2023 (the "Extension"). An extraordinary general meeting of the Company's shareholders ("Special Meeting") to approve the Extension Amendment will be held on August 12, 2022 at 10:00 AM, Eastern Time and can be accessed virtually by visiting https://www.cstproxy.com/edocacquisition/2022. The Extension will provide Edoc with additional time to

    8/4/22 5:17:16 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Edoc Acquisition Corp. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Edoc Acquisition Corp. (Amendment)

    SC 13G/A - Edoc Acquisition Corp. (0001824884) (Subject)

    2/14/24 12:48:37 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G/A filed by Edoc Acquisition Corp. (Amendment)

    SC 13G/A - Edoc Acquisition Corp. (0001824884) (Subject)

    2/13/24 4:41:59 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G/A filed by Edoc Acquisition Corp. (Amendment)

    SC 13G/A - Edoc Acquisition Corp. (0001824884) (Subject)

    1/31/24 6:08:55 AM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G/A filed by Edoc Acquisition Corp. (Amendment)

    SC 13G/A - Edoc Acquisition Corp. (0001824884) (Subject)

    2/23/23 5:01:46 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G/A filed by Edoc Acquisition Corp. (Amendment)

    SC 13G/A - Edoc Acquisition Corp. (0001824884) (Subject)

    2/16/23 4:42:05 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13D/A filed by Edoc Acquisition Corp. (Amendment)

    SC 13D/A - Edoc Acquisition Corp. (0001824884) (Subject)

    2/14/23 5:07:47 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Edoc Acquisition Corp.

    SC 13G - Edoc Acquisition Corp. (0001824884) (Subject)

    2/14/23 3:09:32 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Edoc Acquisition Corp.

    SC 13G - Edoc Acquisition Corp. (0001824884) (Subject)

    2/14/23 9:39:08 AM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G/A filed by Edoc Acquisition Corp. (Amendment)

    SC 13G/A - Edoc Acquisition Corp. (0001824884) (Subject)

    2/13/23 4:23:59 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G/A filed by Edoc Acquisition Corp. (Amendment)

    SC 13G/A - Edoc Acquisition Corp. (0001824884) (Subject)

    2/13/23 2:03:18 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care